Epiloid provides high content readouts of electrophysiological and transcriptomic changes in human cerebral organoids.
Epiloid provides high content readouts of electrophysiological and transcriptomic changes in human cerebral organoids.
Epiloid provides high content readouts of electrophysiological and transcriptomic changes in human cerebral organoids.
Our techniques enable preclinical functional testing of neurotherapeutics in human brain tissue constructs. These organoids recreate the functional and structural components of the human brain with unparalleled in vitro accuracy.
Our techniques enable preclinical functional testing of neurotherapeutics in human brain tissue constructs. These organoids recreate the functional and structural components of the human brain with unparalleled in vitro accuracy.
Our techniques enable preclinical functional testing of neurotherapeutics in human brain tissue constructs. These organoids recreate the functional and structural components of the human brain with unparalleled in vitro accuracy.
~94% of neurology drugs fail to make it through clinical testing, due in large part to poor translation from preclinical tests. Why leave your drug development up to chance? Our custom machine learning algorithms predict human drug efficacy with a 93% accuracy for epilepsy therapeutics.
~94% of neurology drugs fail to make it through clinical testing, due in large part to poor translation from preclinical tests. Why leave your drug development up to chance? Our custom machine learning algorithms predict human drug efficacy with a 93% accuracy for epilepsy therapeutics.
~94% of neurology drugs fail to make it through clinical testing, due in large part to poor translation from preclinical tests. Why leave your drug development up to chance? Our custom machine learning algorithms predict human drug efficacy with a 93% accuracy for epilepsy therapeutics.
